Urbano
Anido Herranz
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (6)
2024
2023
-
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
European Journal of Cancer, Vol. 185, pp. 105-118
2022
-
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study
Clinical Genitourinary Cancer, Vol. 20, Núm. 1, pp. 25-34
2018
-
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma
BMC Pharmacology and Toxicology, Vol. 19, Núm. 1
2016
-
Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: A Spanish expanded access trial
Orphanet Journal of Rare Diseases, Vol. 11, Núm. 1
2013
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572